InvestorsHub Logo
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: None

Wednesday, 03/02/2016 1:13:23 PM

Wednesday, March 02, 2016 1:13:23 PM

Post# of 702026
Anyone like to suggest the cancer indications they should go after in Direct phase 2?
Where is the greatest application, where is the least competition?
They clearly have a wide choice.

Should they go broad brush, or perhaps narrow down to patients, with a particular genetic subtype, or those with high cytokine secretion?

Anything to move this board on from the tedious, cynical pessimism....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News